)

Poly Medicure (531768) investor relations material
Poly Medicure M&A Announcement summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Deal rationale and strategic fit
Acquisition provides entry into the fast-growing global orthopaedic trauma and extremity segment, a resilient $12 billion market expected to reach $16 billion, leveraging a differentiated, MDR-certified and patented product portfolio with strong positions in Italy, Mexico, and a growing U.S. presence.
The deal aligns with a strategy to expand into high-growth medical device segments, leveraging CTFE as a platform for global orthopedic expansion and accelerating growth in developed markets.
Integrated business model from R&D to distribution enables agile product development, rapid market entry, and strengthens innovation pipeline.
Direct sales presence in Italy, USA, and Mexico, with strong market positions in Italy and Mexico, supports global expansion ambitions.
Citieffe's strong R&D and patented portfolio align with the acquirer's mission to deliver innovative, patient-centric technologies.
Financial terms and conditions
100% equity acquired for €18.8 million, with €4.2 million shareholder loan repayment, totaling €23 million payout at closing; €8.1 million net external debt assumed, valuing the company at €31 million enterprise value (EV/EBITDA 10.2x FY24).
CTFE/Citieffe reported €17.3 million revenue and €3.1 million EBITDA in 2024, with gross margins exceeding 90% and YoY growth of 15% and 14%, respectively.
Net block stands at €5 million, with total historical investment around $30 million.
Funded by internal accruals and cash balances.
Synergies and expected cost savings
Immediate synergy from adding plates and joint replacement to the product portfolio, enabling participation in more public tenders and entry into new markets.
Potential to double CTFE's business in five years by leveraging distribution networks and expanding into new geographies.
Outsourcing manufacturing to India expected to reduce costs, improve margins, and build a direct sales unit for CTFE products in India.
Synergies expected from integrating distribution networks and local manufacturing to enhance competitiveness and lower costs.
Expansion of distribution in markets where CTFE currently lacks presence.
Next Poly Medicure earnings date

Next Poly Medicure earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage